Peptides recognized by melanoma-specific a1-, a2- and...

Details Peptides recognized by melanoma-specific a1-, a2- and... Peptides recognized by melanoma-specific a1-, a2- and...

C - Chemistry, Metallurgy

07

K

C07K 14/74 (2006.01) A61K 38/08 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 39/385 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 7/06 (2006.01) C07K 14/47 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2249390

Melanoma-specific, A1-restricted CTL epitopes have been identified in tyrosinase, and may be used in conjunction with other A1- A2- and/or A3-restricted epitopes of tyrosinase, pMel-17 and other melanoma antigens in the design of vaccines.

Affiliated with

Also associated with

Rating

Peptides recognized by melanoma-specific a1-, a2- and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides recognized by melanoma-specific a1-, a2- and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides recognized by melanoma-specific a1-, a2- and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1687867